倾向匹配的五年心脏再同步治疗治疗结果在沙丘病与心力衰竭中的沙丘病
Yong Hao Yeo1, Tze Ern Ong2, Aravinthan Vignarajah3
1Department of Internal Medicine/Pediatrics, Corewell Health William Beaumont University Hospital, Royal Oak, Michigan, USA.
Journal of cardiovascular electrophysiology
|November 25, 2025
概括
心脏再同步疗法 (CRT) 显示了类似的长期结果,以ICD-only植入心力衰竭与减少喷射率 (HFrEF) 患者与肉类瘤. 这包括死亡率,住院率和心力衰竭恶化率.
科学领域:
- 心脏病学 心脏病学
- 电子生理学 电子生理学
- 心脏衰竭管理的管理
背景情况:
- 心脏再同步疗法 (CRT) 是为心力衰竭与减少喷射率 (HFrEF) 建立的.
- 有限的数据存在于CRT在HFrEF患者的药性硬化症的疗效.
研究的目的:
- 为了比较CRT与ICD的长期结果,仅在患有HFrEF的类病患者中植入ICD.
- 评估对死亡率,住院,心力衰竭恶化和LVEF改善的影响.
主要方法:
- 使用TriNetX网络 (2014-2019) 的回顾性队列研究.
- 鉴定出HFrEF患者患有肉类发病,LVEF<35%,以及LBBB或QRS>150ms.
- 仅使用CRT和ICD组之间的5年结果比较.
主要成果:
- 87名患者接受CRT,87名患者仅接受ICD (类似的倾向分数).
- 在五年全因死亡率 (14.9%对20.7%),住院 (83.9%对77.0%) 或心力衰竭恶化 (28.7%对28.7%) 中没有显著差异.
- 在两组中都观察到类似的LVEF改善率.
结论:
- 在患有HFrEF的肉病患者中,CRT植入产生了与仅ICD植入相似的长期结果.
- 在这个特定人群中,没有观察到CRT对死亡率,住院或心力衰竭恶化的显著益处.
相关概念视频
Cardiomyopathy V: Interprofessional Care
316
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
316
Cardiomyopathy III: Hypertrophic Cardiomyopathy
378
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
378
Cardiomyopathy II: Dilated Cardiomyopathy
449
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
449
Heart Failure IV: Classification and Diagnostic Evaluation
300
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
300
Heart Failure Drugs: Inotropic Agents
1.2K
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
1.2K
Cardiomyopathy IV: Restrictive Cardiomyopathy
432
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
432


